MIT Holding Inc. Partners with MEVLABS Inc. to Research Novel Technologies and Therapeutics for Infectious Diseases

SAVANNAH, Ga.--(BUSINESS WIRE)--MIT Holding, Inc. (OTCBB: MITD) has partnered with MEVLABS, Inc., a research and development company focused on infectious diseases that afflict world health, to research certain infectious diseases that are distressing countries worldwide. As part of the agreement, MIT will provide funding for the preventive and clinical research, marketing and global licensing of products that are developed through the relationship. MEVLABS will be responsible for field and clinical research and production of samples for regulatory authorities to review. Other terms of the agreement were not disclosed.